Mitochondrial encephalopathy: Clinical Trials

2 trials for Mitochondrial encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 31Terminated 1

Follow Mitochondrial encephalopathy: new trials by email Literature Review of Mitochondrial encephalopathy trials Research Report on Mitochondrial encephalopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
zagociguat 15mg - Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Phase 2TerminatedTisento Therapeutics372025-08-182026-10-30
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy
Phase 2 / Phase 3TerminatedPTC Therapeutics682020-09-282026-03-31

Narrower conditions

MELAS Syndrome (2)  ·  Acidosis, Lactic (1)  ·  Diffuse Cerebral Sclerosis of Schilder (1)  ·  Drug Resistant Epilepsy (1)  ·  Leigh Disease (1)  ·  MERRF Syndrome (1)  ·  Mitochondrial Diseases (1)  ·  Nerve Degeneration (1)  ·  Pontocerebellar Hypoplasia Type 6 (1)  ·  Seizures (1)  ·  Status Epilepticus (1)

Broader conditions

Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebral Small Vessel Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Metabolic Diseases (2)  ·  Metabolism, Inborn Errors (2)  ·  Mitochondrial Encephalomyopathies (2)  ·  Mitochondrial Myopathies (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)

Interventions

alpha-tocotrienol quinone (1)

Sponsors

PTC Therapeutics (1)  ·  Tisento Therapeutics (1)

Countries

Italy (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Vinay Penematsa, MD (1)